2 min read

Mandate and Role:

The Singapore Health Sciences Authority (HSA) is Singapore’s multidisciplinary national authority tasked with the protection and advancement of national health and safety. It is best known as the country’s regulator for health products, ensuring that such products are controlled to meet strict standards for safety, quality, and efficacy.

The Singapore Health Sciences Authority (HSA) also plays a central role in strengthening Singapore pharmaceutical regulations through robust product evaluation, market surveillance, and Regulatory enforcement. As Singapore continues positioning itself as a leading healthcare and biomedical hub in Asia, companies pursuing health product registration Singapore must align with HSA’s evolving Regulatory framework and compliance expectations.

Main Functions & Scope:

  1. Regulation of Health Products
    1. HSA regulates a wide array of products, including medicines, innovative therapeutics, medical devices, health supplements, cosmetics, and traditional medicines.
    2. The agency has received affirmation from the World Health Organization (WHO) for its advanced performance in market surveillance and control for medicines, covering generics, new chemical entities, and biotherapeutics.
  2. National Blood Service
    1. Provides for and maintains a safe and adequate national blood supply.
  3. Applied Sciences
    1. HSA applies scientific, forensic, investigative, and analytical expertise to support the administration of justice (e.g., in criminal investigations and public health emergencies).

Organizational Structure:

HSA operates through three core professional groups:

  • Health Products Regulation Group (HPRG): Regulates health products and contributes to Singapore’s biomedical sciences sector by ensuring products meet Regulatory standards.
  • Blood Services Group: Ensures collection, testing, and supply of blood.
  • Applied Sciences Group: Delivers forensic and analytical services for law enforcement and legal support.

Key Regulatory Responsibilities:

  • Licensing and registration of manufacturers, importers, and wholesalers dealing with therapeutic and other regulated health products.
  • Surveillance, recall, and vigilance on health products to maintain safety standards.
  • Guidance on product defect reporting, recall procedures, and post-market vigilance requirements.
  • Evaluation and regulation of clinical trials, including expedited safety reporting for HSA-authorized trials.
  • Oversight of advertisements and promotional activities for health products.

HSA also continues strengthening HSA clinical trial regulations to support innovative therapies, advanced biologics, and regional clinical research expansion while maintaining patient safety and Regulatory transparency.

International Standing:

  • HSA is internationally recognized and has attained WHO-Listed Authority (WLA) status, indicating its compliance with global standards for all Regulatory functions regarding medicines

Conclusion 

Navigating the Singapore Health Sciences Authority (HSA) Regulatory framework requires strategic planning, technical expertise, and continuous compliance management. From therapeutic product registration and clinical trial approvals to post-market vigilance and lifecycle maintenance, companies must align with Singapore’s stringent Regulatory expectations to ensure successful market entry and long-term compliance.

With extensive expertise in Singapore pharmaceutical regulations, Regulatory strategy, dossier preparation, and compliance support, Freyr Solutions helps organizations streamline Regulatory pathways and accelerate market entry in Singapore through tailored end-to-end Regulatory solutions.

To learn more about how Freyr can support your Regulatory needs in Singapore, fill out the contact form or write to us at sales@freyrsolutions.com.